RE: Re: What financial resources6 Jul 2020 12:54
Yes to me it is very clear. "Financial resources" does not mean a placing or placings. It means the funds will be provided from an external source such as a partner or collaborator. This quote confirms what I am saying:
"It is intended that new projects will be held in newly formed subsidiaries ("Special Purpose Vehicles" or "SPVs") with the Company seeking external funding from partners to progress development towards clinical trials. ValiRx will provide the SPVs with corporate and project management support, being reimbursed accordingly. In the longer term, it is the objective that the incubation of early stage drug discovery projects become self-sustaining, with income from SPVs being used to support the working capital requirement of ValiRx and provide investment funding for further in-licensing."
The next stage would be that the projects enable the company to ultimately become self financing ie.no more placings. That is clearly a more longer term objective but it is clear that Suzanne Dilly is setting out a very clear vision, business model for the group.
It is IMO encouraging for anybody considering investing and certainly assuring for existing shareholders.
Like others have commented I get the impression that something is in the short term pipeline. Our first deal to demonstrate the new strategy and definitely hinting at a forthcoming deal with the Japanese pharma.